A case of primary meningeal melanocytosis treated with combination therapy with nivolumab and ipilimumab

J Dermatol. 2023 Apr;50(4):e125-e126. doi: 10.1111/1346-8138.16658. Epub 2022 Nov 28.

Authors

Affiliations

¹ Department of Dermatology, International University of Health and Welfare, Narita, Japan.
² Department of Diagnostic Pathology, International University of Health and Welfare, Narita, Japan.
³ Department of Neurosurgery, International University of Health and Welfare, Narita, Japan.

PMID: 36440954
DOI: 10.1111/1346-8138.16658

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal / therapeutic use
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Combined Modality Therapy
Humans
Ipilimumab
Melanoma* / diagnosis
Melanoma* / drug therapy
Nivolumab* / therapeutic use

Substances

Nivolumab
Ipilimumab
Antibodies, Monoclonal